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of new or unusual infections (2,3).
This information is essential for pub-
lic health and medical interventions.
As outlined by Louie et al., hospi-
tal autopsy rates have dropped to sin-
gle digits, and concerns by patholo-
gists about occupational risks and
biosafety have likely contributed to
this decline. Currently, the last strong-
hold of autopsy expertise is forensic
pathology (4). However, the
medicolegal death investigative sys-
tem does not have jurisdiction over all
potential infectious disease deaths nor
is it adequately supported to assume
the cases that are missed by our pres-
ent hospital autopsy system.
Additionally, many medicolegal and
hospital autopsy facilities with outdat-
ed or poorly-designed air flow sys-
tems are ill suited to handle autopsies
when infectious disease is suspected
(5). Air-handling systems can be
expensive to fix.
Reference centers such as the
National Prion Disease Pathology
Surveillance Center, while providing
diagnostic expertise, fail to surmount
the biosafety obstacles (real and per-
ceived) that prevent pathologists from
enthusiastically performing autopsies
on those who died of potential infec-
tious diseases, including prion dis-
eases. One potential solution is the
creation of regional centers of excel-
lence for infectious disease autopsies
that could operate in conjunction with
a mobile containment autopsy facility
(5,6). Such centers could provide
diagnostic expertise as well as
biosafety capacity.
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To the Editor: To the list of
zoonotic infections with wildlife
sources reported by Kruse et al. (1), I
would add Coxiella burnetii infection
because of its global impact, exten-
sive presence in the animal kingdom,
and potential for use as an agent of
bioterrorism (2). C. burnetii causes Q
fever, a self-limited disease that usual-
ly appears as undifferentiated fever,
pneumonia, or hepatitis, but which
may progress into chronic disease,
especially endocarditis, among sus-
ceptible persons. Q fever is endemic
worldwide in domestic mammals,
especially ungulates (cattle, sheep,
and goats), but also has been found in
wild mammals, birds, and arthropods.
The transmission of Q fever to
humans from wild rabbits was docu-
mented in the 1980s (3). More recent-
ly, a study showed seroprevalence of
Q fever ranging from 7% to 53% in
brown rats (Rattus norvegicus) in
Oxfordshire, which suggests that they
are a possible reservoir for C. burnetii
in the United Kingdom. The study
also speculated why cats, as frequent
predators of rats, are important in
maintaining the transmission cycle of
the disease (4).
A case-control study published in
2001 (5) attempted to define the risk
factors for an increase in the incidence
of Q fever in French Guiana in 1996.
The study found no link between Q
fever and domestic ungulates, the
usual source of outbreaks. The role of
pets, basically dogs and cats, as a
reservoir was also excluded.
Multivariate analysis showed that liv-
ing in close proximity to the forest,
exposure to wild animals (including
bats), and working in public trade or
public works were all associated with
infection. A strong correlation
between large amounts of rainfall and
higher incidence of Q fever was found
also. All of these findings suggested a
wild reservoir as a potential source of
the epidemics, although the
researchers could not identify a par-
ticular species as the specific source.
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To the Editor: The Polio
Eradication Campaign was started in
Thailand in 1990, and the last polio
case was reported in April 1997.
Although no new cases have been
reported, the Polio Eradication
Campaign continues with 4 preven-
tion strategies: high coverage with 3
doses of oral polio in children <1 year
of age, acute flaccid paralysis surveil-
lance, acute flaccid paralysis case
investigation and response, and
National Immunization Day. Also, the
Ministry of Public Health is prepared
for a national emergency response to
polio importation and circulated vac-
cine–derived poliovirus (1).
In April 2003, a case of acute flac-
cid paralysis was reported from
Phakhao district, Loei province. The
patient was an 18-month-old boy with
normal physical development and
nutritional status. He had a history of
mild asthma and had received bron-
chodilator drugs occasionally during
upper respiratory tract infections in
the past. The patient had been fully
vaccinated. He had received a total of
5 doses of oral polio vaccine: a dose at
2, 4, and 6 months of age, and 2 doses
on National Immunization Day in
December 2002 and January 2003.
On March 27, 2003, while visiting
his grandmother in Phoowiang dis-
trict, Khonkaen province (80 km from
his residence), the patient became ill.
Pneumonia was diagnosed; injected
medications were administered into
his left hip once a day for 3 days. The
patient fully recovered.
On April 1, 2003, cellulitis of finger
developed in the patient. The affected
finger was incised and drained, and
oral antimicrobial drugs were adminis-
tered. The inflammation extended to
his elbow but later subsided.
On April 7, fever, cough, and dys-
pnea developed in the patient. Two
days later, the patient’s left leg
became weak. He was admitted to
Phakhao Hospital with a diagnosis of
pneumonia and with weakness in his
left leg. He was later referred to Loei
Provincial Hospital and acute flaccid
paralysis was diagnosed on April 11.
The muscle weakness progressed
until he could not sit. 
On April 14, the patient was
referred to Khonkaen Regional
Hospital with weakness in both legs
and arms (grade 0–1). Chest radi-
ograph showed perihilar pneumonia.
Cloxacillin, gentamicin, and
immunoglobulin (Ig) (6 g/day × 4
days, patient weight 12 kg) were
administered intravenously to the
patient. He was discharged on April
30 with a diagnosis of Guillain-Barré
syndrome and bacterial pneumonia.
The muscle tone in his right leg and
both arms was grade 3; however, he
could not move his left leg.
Stool samples were collected on
April 11 and 14 and tested for polio at
the Department of Medical Science
(reference laboratory for polio in
Southeast Asia). Poliovirus type 2 was
isolated in the samples; however, the
results were inconclusive for strain
differentiation. The isolates were sent
to the Centers for Disease Control and
Prevention (CDC), USA, for genetic
sequencing, and the result showed
poliovirus type 2 with 1.6% differ-
ence from Sabin strain poliovirus.
Without evidence of recombination
with other nonpolio enterovirus, the
pattern of genomic change was simi-
lar to the change that occurs in
immunodeficient persons. Immune
system testing of the patient on
August 13 showed IgG = 205.9
mg/dL (normal 800–1,700), IgA <5.5
mg/dL (normal 100–490), IgM <16.8
mg/dL (normal 50–320), and IgE
<18.0 mg/dL (normal 0–100). Anti-
bodies to poliovirus type 1, 2, and 3
were 1:16, 1:32, and 1:8, respectively.
Testing of the follow-up stool samples
showed P1/Sabin on August 10. Test
results were negative on October 13,
and results showed nonpolio
enterovirus on November 10 and
December 14. 
Before the large-scale outbreak
response immunization was conduct-
ed, 339 serum samples were collected
from children <5 years of age who
lived in the same district as the patient
or in the same subdistrict as his grand-
mother. Among 153 children who
brought their vaccination records, the
median dose of oral polio vaccine was
7 (range 2–15). All had antibody >1:8
to poliovirus types 1, 2, and 3.
Approximately 2,000 stool samples
were collected from children <5 year
of age who lived in the same district
as the case-patient or his grandmother.
However, after the immunodeficien-
cies vaccine–derived poliovirus was
identified, isolation of the virus was
attempted only from stool samples
from children who lived in the same
subdistrict as the patient. From 223
stool samples, 4 Sabin strain
poliovirus and 32 nonpolio entero-
viruses were isolated. In addition, 2 of
18 stool samples collected in July
from close contacts of the case-patient
were positive for Sabin strain
poliovirus and negative for vaccine–
derived poliovirus. 
The Loei Provincial Health Office
initially did a small-scale response
immunization in 3 adjacent villages
(128 of 129 children) on the day that
the case of acute flaccid paralysis was
reported. Coverage of third dose of
oral polio vaccine in these villages
was 100%. No response immuniza-
tion was conducted at the village in
Khonkaen. On August 8, genetic
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